Target intelligence / Profile preview

Mucin disulfide networks in airway mucus

Molecular classification
Glycoprotein, Other
01

Overview

Mucin disulfide networks are the fundamental structural framework of the airway mucus gel, primarily composed of the large, secreted polymeric glycoproteins MUC5AC and MUC5B [Fahy, 2010]. These mucins undergo extensive post-translational modification and form massive, high-molecular-weight oligomers through disulfide bond formation between cysteine-rich D-domains at their N- and C-termini [Thornton, 2008]. This cross-linked network is essential for the viscoelastic properties of mucus, which allow it to trap inhaled particles and be transported out of the lungs by ciliary action [Bonser, 2017]. In pathological states like cystic fibrosis, COPD, and severe asthma, the density of these disulfide cross-links increases or the mucus becomes dehydrated, resulting in stagnant, thick mucus that obstructs the airways and promotes infection [Bonser, 2017]. Therapeutic intervention typically utilizes mucolytic agents, such as N-acetylcysteine, which contain free thiol groups that participate in thiol-disulfide exchange reactions to break the mucin polymers into smaller, less viscous fragments [Yuan, 2015]. By reducing the connectivity of the disulfide network, these drugs facilitate the clearance of obstructive mucus and improve lung function in patients with chronic respiratory diseases [Fahy, 2010].

Other names
Mucin polymersDisulfide-linked mucin oligomersAirway mucus gelMUC5AC/MUC5B networks
02

Mechanism of action

Reduction of intermolecular disulfide bonds via thiol-disulfide exchange, leading to the fragmentation of mucin polymers and reduction of mucus viscoelasticity.

03

Biological functions

Immune responseOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

BronchospasmAirway irritationDisruption of protective mucosal barrier
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Sputum viscoelasticityMUC5AC/MUC5B protein levelsMucus percent solids

Beyond the preview

Go deeper on Mucin disulfide networks in airway mucus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin disulfide networks in airway mucus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call